Amgen and LabCentral biopharma partners: announced an agreement in which Amgen has become a LabCentral platinum sponsor.
As part of the sponsorship agreement, Amgen can nominate up to two promising life-sciences and biotech startup companies per year to take up residence in LabCentral's Kendall Square facilities.
"Amgen, with its deep expertise as a developer of biotech-based drugs, is an ideal partner for many of LabCentral's resident companies working on promising new biopharmaceuticals," said LabCentral President Johannes Fruehauf, Ph.D., M.D.
|Searching for more deal information? Current Partnering offers the following options:
"We're thrilled that Amgen has joined as our newest sponsor and look forward to working with the Amgen team to support these early-stage entrepreneurs and to help accelerate development of new therapies to improve human health."
For further deal information visit Current Agreements (subscription required)
Scorecard: Top partnering deals by value in 2014
View: Top biotech companies
Report: Top 50 Big Biotech Partnering and M&A Deal Trends